Disruption of the SHH signaling pathway, which requires intact cilia, might be a mechanism of neuronal vulnerability in PD patients with LRRK2 mutations, and monitoring extracellular levels of SHH via quantification from EVs might be a promising approach to, for example, monitor treatment efficacies (Khan et al., 2021). This evidence concerns the gene LRRK2 and Parkinson disease.